Samik Pharm삼익제약
014950 · KOSDAQ · ₩014950 · 삼익제약
₩7,690▲ ₩670 (9.54%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 23, 2026Open on DART
Predicted impact: Low
- Investor relations (IR) event기업설명회(IR)개최Oct 22, 2026Open on DART
Predicted impact: Low
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 23, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 6, 2026Open on DART
- Results of Extraordinary Shareholders' Meeting임시주주총회결과Jul 3, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jun 25, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Jun 18, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 4, 2026Open on DART
- Shareholders' meeting called주주총회소집결의 (임시주주총회)May 27, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정May 27, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 19, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Corporate value-up plan기업가치제고계획(자율공시) (2026년 삼익제약(주) 기업가치 제고 계획)May 6, 2026Open on DART
- Exercise of Conversion Rights (1st Series)전환청구권행사 (제1회차)Apr 9, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 31, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 26, 2026Open on DART
- Audit report submitted감사보고서제출Mar 20, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 20, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 6, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 27, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 27, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 27, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 7, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- Major Matters Report (Business Suspension)주요사항보고서(영업정지)Nov 26, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 31, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 31, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 31, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 31, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 31, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Oct 31, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Oct 31, 2025Open on DART
- New Facility Investment, etc.신규시설투자등Oct 30, 2025Open on DART
- Securities Issuance Results Report (Merger, etc.)증권발행실적보고서(합병등)Oct 14, 2025Open on DART
- Prospectus투자설명서Aug 11, 2025Open on DART
- Amended: Securities registration statement[기재정정]증권신고서(합병)Jul 30, 2025Open on DART
- Securities registration statement증권신고서(합병)Jul 21, 2025Open on DART
- Consolidated Audit Report (2024.12)연결감사보고서 (2024.12)Apr 10, 2025Open on DART
- Audit Report (2024.12)감사보고서 (2024.12)Apr 10, 2025Open on DART
- Audit Report (2023.12)감사보고서 (2023.12)Apr 1, 2024Open on DART
- 감사보고서 (2022.12)Apr 3, 2023Open on DART
Titles in Korean until English translations are added.
Also known as: Samik Pharm / 삼익제약 / 014950 / KRX:014950
Source: KRX statistical information